These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 3029269)

  • 1. Simian virus 40 (SV40)-transgenic mice that develop tumors are specifically tolerant to SV40 T antigen.
    Faas SJ; Pan S; Pinkert CA; Brinster RL; Knowles BB
    J Exp Med; 1987 Feb; 165(2):417-27. PubMed ID: 3029269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune control of SV40-induced tumors in mice.
    Pan S; Abramczuk J; Knowles BB
    Int J Cancer; 1987 Jun; 39(6):722-8. PubMed ID: 3034805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.
    Ye X; McCarrick J; Jewett L; Knowles BB
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3916-20. PubMed ID: 8171012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic selection of simian virus 40 (SV40) T-antigen-negative tumor cells which arise by excision of early SV40 DNA.
    Mora PT; Parrott CL; Baksi K; McFarland V
    J Virol; 1986 Sep; 59(3):628-34. PubMed ID: 3016325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of SV40-specific cytotoxic T-lymphocyte precursors in two SV40 T-antigen transgenic mouse lines.
    Juretic A; Knowles BB
    APMIS; 1991 Mar; 99(3):213-8. PubMed ID: 1850285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential loss of cytotoxic T lymphocyte responses to simian virus 40 large T antigen epitopes in T antigen transgenic mice developing osteosarcomas.
    Schell TD; Knowles BB; Tevethia SS
    Cancer Res; 2000 Jun; 60(11):3002-12. PubMed ID: 10850449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells.
    Shearer MH; Bright RK; Lanford RE; Kennedy RC
    Clin Exp Immunol; 1993 Feb; 91(2):266-71. PubMed ID: 7679059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleic acid vaccination against virally induced tumors.
    Bright RK; Shearer MH; Kennedy RC
    Ann N Y Acad Sci; 1995 Nov; 772():241-51. PubMed ID: 8546399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of simian virus 40-transformed C57BL/6 mouse embryo fibroblasts to lysis by murine natural killer cells.
    Fresa KL; Karjalainen HE; Tevethia SS
    J Immunol; 1987 Feb; 138(4):1215-20. PubMed ID: 3027174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo expansion of the residual tumor antigen-specific CD8+ T lymphocytes that survive negative selection in simian virus 40 T-antigen-transgenic mice.
    Schell TD
    J Virol; 2004 Feb; 78(4):1751-62. PubMed ID: 14747540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
    Newmaster RS; Mylin LM; Fu TM; Tevethia SS
    Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
    Shearer MH; Bright RK; Kennedy RC
    Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SV40 T antigen acts as a minor histocompatibility antigen of SV40 T antigen tolerant transgenic mice.
    Juretic A; Knowles BB
    Immunogenetics; 1989; 29(6):366-70. PubMed ID: 2786497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of a simian virus 40 T-antigen-positive, transformation-resistant cell line by indirect selection.
    Ryan KW; Christensen JB; Imperiale MJ; Brockman WW
    Mol Cell Biol; 1985 Dec; 5(12):3577-82. PubMed ID: 3018524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice.
    Schell TD; Mylin LM; Georgoff I; Teresky AK; Levine AJ; Tevethia SS
    J Virol; 1999 Jul; 73(7):5981-93. PubMed ID: 10364350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large T antigens of simian virus 40 and polyomavirus efficiently establish primary fibroblasts.
    Jat PS; Sharp PA
    J Virol; 1986 Sep; 59(3):746-50. PubMed ID: 3016337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluctuation of simian virus 40 (SV40) super T-antigen expression in tumors induced by SV40-transformed mouse mammary epithelial cells.
    Butel JS; Wong C; Evans BK
    J Virol; 1986 Nov; 60(2):817-21. PubMed ID: 3022016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumorigenesis in transgenic mice by a nuclear transport-defective SV40 large T-antigen gene.
    Pinkert CA; Brinster RL; Palmiter RD; Wong C; Butel JS
    Virology; 1987 Sep; 160(1):169-75. PubMed ID: 2820126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SV40 T-antigen is a histocompatibility antigen of SV40-transgenic mice.
    Wettstein PJ; Jewett L; Faas S; Brinster RL; Knowles BB
    Immunogenetics; 1988; 27(6):436-41. PubMed ID: 2836306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.